Derivates of the Antifungal Peptide Cm-p5 Inhibit Development of Candida auris Biofilms In Vitro
Abstract
:1. Introduction
2. Results and Discussion
3. Materials and Methods
3.1. Cultivation of C. auris
3.2. Biofilm Formation and Quantification
3.3. Effects of Cm-p5 Derivatives on Mature Biofilms
4. Conclusions
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Nadell, C.D.; Bassler, B.L.; Levin, S.A. Observing bacteria through the lens of social evolution. J. Biol. 2008, 7, 27. [Google Scholar] [CrossRef] [PubMed]
- Licking, E. Getting a grip on bacterial slime. Bus. Week 1999, 13, 98–100. [Google Scholar]
- Davies, D. Understanding biofilm resistance to antibacterial agents. Nat. Rev. Drug Discov. 2003, 2, 114–122. [Google Scholar] [CrossRef] [PubMed]
- Fox, E.P.; Nobile, C.J. A sticky situation: Untangling the transcriptional network controlling biofilm development in Candida albicans. Transcription 2012, 3, 315–322. [Google Scholar] [CrossRef] [PubMed]
- Papon, N.; Courdavault, V.; Clastre, M.; Bennett, R.J. Emerging and Emerged Pathogenic Candida Species: Beyond the Candida albicans Paradigm. PLoS Pathog. 2013, 9. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Satoh, K.; Makimura, K.; Hasumi, Y.; Nishiyama, Y.; Uchida, K.; Yamaguchi, H. Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol. Immunol. 2009, 53, 41–44. [Google Scholar] [CrossRef]
- Morales-López, S.E.; Parra-Giraldo, C.M.; Ceballos-Garzón, A.; Martínez, H.P.; Rodríguez, G.J.; Álvarez-Moreno, C.A.; Rodríguez, J.Y. Invasive infections with multidrug-resistant yeast Candida auris, Colombia. Emerg. Infect. Dis. 2017, 23, 162–164. [Google Scholar] [CrossRef] [Green Version]
- Lockhart, S.R.; Etienne, K.A.; Vallabhaneni, S.; Farooqi, J.; Chowdhary, A.; Govender, N.P.; Colombo, A.L.; Calvo, B.; Cuomo, C.A.; Desjardins, C.A.; et al. Simultaneous emergence of multidrug-resistant candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin. Infect. Dis. 2017, 64, 134–140. [Google Scholar] [CrossRef] [Green Version]
- Osei Sekyere, J. Candida auris: A systematic review and meta-analysis of current updates on an emerging multidrug-resistant pathogen. Microbiologyopen 2018, 7, e00578. [Google Scholar] [CrossRef] [Green Version]
- Forbes. Available online: https://www.forbes.com/sites/judystone/2017/08/24/candida-auris-a-new-fungal-superbug-emerging-as-a-global-threat/ (accessed on 14 May 2020).
- Ben-Ami, R.; Berman, J.; Novikov, A.; Bash, E.; Shachor-Meyouhas, Y.; Zakin, S.; Maor, Y.; Tarabia, J.; Schechner, V.; Adler, A.; et al. Multidrug-resistant candida haemulonii and C. Auris, tel aviv, Israel. Emerg. Infect. Dis. 2017, 23, 195–203. [Google Scholar] [CrossRef]
- Kean, R.; Delaney, C.; Sherry, L.; Borman, A.; Johnson, E.M.; Richardson, M.D.; Rautemaa-Richardson, R.; Williams, C.; Ramage, G. Transcriptome Assembly and Profiling of Candida auris Reveals Novel Insights into Biofilm-Mediated Resistance. mSphere 2018, 3. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ciociola, T.; Giovati, L.; Conti, S.; Magliani, W.; Santinoli, C.; Polonelli, L. Natural and synthetic peptides with antifungal activity. Future Med. Chem. 2016, 8, 1413–1433. [Google Scholar] [CrossRef] [PubMed]
- Rautenbach, M.; Troskie, A.M.; Vosloo, J.A. Antifungal peptides: To be or not to be membrane active. Biochimie 2016, 130, 132–145. [Google Scholar] [CrossRef] [PubMed]
- López-Abarrategui, C.; McBeth, C.; Mandal, S.M.; Sun, Z.J.; Heffron, G.; Alba-Menéndez, A.; Migliolo, L.; Reyes-Acosta, O.; García-Villarino, M.; Nolasco, D.O.; et al. Cm-p5: An antifungal hydrophilic peptide derived from the coastal mollusk Cenchritis muricatus (Gastropoda: Littorinidae). FASEB J. 2015, 29, 3315–3325. [Google Scholar] [CrossRef] [Green Version]
- Kubiczek, D.; Flaig, C.; Raber, H.; Dietz, S.; Kissmann, A.K.; Heerde, T.; Bodenberger, N.; Wittgens, A.; González-Garcia, M.; Kang, F.; et al. A Cerberus-Inspired Anti-Infective Multicomponent Gatekeeper Hydrogel against Infections with the Emerging “Superbug” Yeast Candida auris. Macromol. Biosci. 2020, 20. [Google Scholar] [CrossRef] [Green Version]
- Morales-Vicente, F.E.; González-Garcia, M.; Diaz Pico, E.; Moreno-Castillo, E.; Garay, H.E.; Rosi, P.E.; Jimenez, A.M.; Campos-Delgado, J.A.; Rivera, D.G.; Chinea, G.; et al. Design of a Helical-Stabilized, Cyclic, and Nontoxic Analogue of the Peptide Cm-p5 with Improved Antifungal Activity. ACS Omega 2019, 4, 19081–19095. [Google Scholar] [CrossRef] [Green Version]
- Høiby, N.; Ciofu, O.; Johansen, H.K.; Song, Z.J.; Moser, C.; Jensen, P.Ø.; Molin, S.; Givskov, M.; Tolker-Nielsen, T.; Bjarnsholt, T. The clinical impact of bacterial biofilms. Int. J. Oral Sci. 2011, 3, 55–65. [Google Scholar] [CrossRef] [Green Version]
- Welsh, R.M.; Bentz, M.L.; Shams, A.; Houston, H.; Lyons, A.; Rose, L.J.; Litvintseva, A.P. Survival, persistence, and isolation of the emerging multidrug-resistant pathogenic yeast Candida auris on a plastic health care surface. J. Clin. Microbiol. 2017, 55, 2996–3005. [Google Scholar] [CrossRef] [Green Version]
- Sherry, L.; Ramage, G.; Kean, R.; Borman, A.; Johnson, E.M.; Richardson, M.D.; Rautemaa-Richardson, R. Biofilm-forming capability of highly virulent, multidrug-resistant Candida auris. Emerg. Infect. Dis. 2017, 23, 328–331. [Google Scholar] [CrossRef] [Green Version]
- O’Toole, G.; Kaplan, H.B.; Kolter, R. Biofilm Formation as Microbial Development. Annu. Rev. Microbiol. 2000, 54, 49–79. [Google Scholar] [CrossRef]
- Villar, C.C.; Kashleva, H.; Nobile, C.J.; Mitchell, A.P.; Dongari-Bagtzoglou, A. Mucosal tissue invasion by Candida albicans is associated with E-cadherin degradation, mediated by transcription factor Rim101p and protease Sap5p. Infect. Immun. 2007, 75, 2126–2135. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Winter, M.B.; Salcedo, E.C.; Lohse, M.B.; Hartooni, N.; Gulati, M.; Sanchez, H.; Takagi, J.; Hube, B.; Andes, D.R.; Johnson, A.D.; et al. Global identification of biofilm-specific proteolysis in Candida albicans. MBio 2016, 7. [Google Scholar] [CrossRef] [Green Version]
- Jose, A.; Coco, B.J.; Milligan, S.; Young, B.; Lappin, D.F.; Bagg, J.; Murray, C.; Ramage, G. Reducing the incidence of denture stomatitis: Are denture cleansers sufficient? J. Prosthodont. 2010, 19, 252–257. [Google Scholar] [CrossRef] [PubMed]
- O’Toole, G.A. Microtiter dish Biofilm formation assay. J. Vis. Exp. 2010. [Google Scholar] [CrossRef] [PubMed]
- Negri, M.; Gonçalves, V.; Silva, S.; Henriques, M.; Azeredo, J.; Oliveira, R. Crystal violet staining to quantity Candida adhesion to epithelial cells. Br. J. Biomed. Sci. 2010, 67, 120–125. [Google Scholar] [CrossRef] [PubMed]
- Sherry, L.; Rajendran, R.; Lappin, D.F.; Borghi, E.; Perdoni, F.; Falleni, M.; Tosi, D.; Smith, K.; Williams, C.; Jones, B.; et al. Biofilms formed by Candida albicans bloodstream isolates display phenotypic and transcriptional heterogeneity that are associated with resistance and pathogenicity. BMC Microbiol. 2014, 14, 182. [Google Scholar] [CrossRef] [Green Version]
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Kubiczek, D.; Raber, H.; Gonzalez-García, M.; Morales-Vicente, F.; Staendker, L.; Otero-Gonzalez, A.J.; Rosenau, F. Derivates of the Antifungal Peptide Cm-p5 Inhibit Development of Candida auris Biofilms In Vitro. Antibiotics 2020, 9, 363. https://doi.org/10.3390/antibiotics9070363
Kubiczek D, Raber H, Gonzalez-García M, Morales-Vicente F, Staendker L, Otero-Gonzalez AJ, Rosenau F. Derivates of the Antifungal Peptide Cm-p5 Inhibit Development of Candida auris Biofilms In Vitro. Antibiotics. 2020; 9(7):363. https://doi.org/10.3390/antibiotics9070363
Chicago/Turabian StyleKubiczek, Dennis, Heinz Raber, Melaine Gonzalez-García, Fidel Morales-Vicente, Ludger Staendker, Anselmo J. Otero-Gonzalez, and Frank Rosenau. 2020. "Derivates of the Antifungal Peptide Cm-p5 Inhibit Development of Candida auris Biofilms In Vitro" Antibiotics 9, no. 7: 363. https://doi.org/10.3390/antibiotics9070363
APA StyleKubiczek, D., Raber, H., Gonzalez-García, M., Morales-Vicente, F., Staendker, L., Otero-Gonzalez, A. J., & Rosenau, F. (2020). Derivates of the Antifungal Peptide Cm-p5 Inhibit Development of Candida auris Biofilms In Vitro. Antibiotics, 9(7), 363. https://doi.org/10.3390/antibiotics9070363